Literature DB >> 16924391

Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy.

Grigorios T Sakellariou1, Periklis Vounotrypidis, Charalampos Berberidis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16924391     DOI： 10.1007/s10067-006-0422-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  13 in total

1.  IgA nephropathy in association with Crohn's disease.

Authors:  M J Forshaw; O Guirguis; T W Hennigan
Journal:  Int J Colorectal Dis       Date:  2005-01-25       Impact factor: 2.571

2.  Inflammatory bowel disease, ankylosing spondylitis, and IgA nephropathy.

Authors:  Carlos Geraldo de Moura; Thiara Gusmão Guerreiro de Moura; Sérgio Pinto de Souza; Leonardo Testagrossa
Journal:  J Clin Rheumatol       Date:  2006-04       Impact factor: 3.517

3.  Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy.

Authors:  Joseph C K Leung; Sydney C W Tang; Loretta Y Y Chan; Anita W L Tsang; Hui Yao Lan; Kar Neng Lai
Journal:  Nephrol Dial Transplant       Date:  2003-01       Impact factor: 5.992

4.  Serum IgG, IgM, and IgA levels in ankylosing spondylitis.

Authors:  E M Veys; M van Leare
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

5.  Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy.

Authors:  Loretta Y Y Chan; Joseph C K Leung; Anita W L Tsang; Sydney C W Tang; Kar Neng Lai
Journal:  Kidney Int       Date:  2005-02       Impact factor: 10.612

6.  Patterns of cytokine production in psoriatic synovium.

Authors:  C Ritchlin; S A Haas-Smith; D Hicks; J Cappuccio; C K Osterland; R J Looney
Journal:  J Rheumatol       Date:  1998-08       Impact factor: 4.666

Review 7.  [A case of IgA nephropathy associated with psoriasis vulgaris].

Authors:  M Yamamoto; T Yorioka; M Kawada; K Nishimura; Y Kumon; N Yasuoka; T Suehiro; K Hashimoto
Journal:  Nihon Jinzo Gakkai Shi       Date:  1994-06

8.  Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions.

Authors:  P Ettehadi; M W Greaves; D Wallach; D Aderka; R D Camp
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

9.  Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial.

Authors:  Manuel Praga; Eduardo Gutiérrez; Ester González; Enrique Morales; Eduardo Hernández
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

10.  Clinicopathological correlation of intrarenal cytokines and chemokines in IgA nephropathy.

Authors:  Chun Soo Lim; Hyung Jin Yoon; Yon Su Kim; Curie Ahn; Jin Suk Han; Suhnggwon Kim; Jung Sang Lee; Hyun Soon Lee; Dong-Wan Chae
Journal:  Nephrology (Carlton)       Date:  2003-02       Impact factor: 2.506
View more
  4 in total

1.  Infliximab treatment for Crohn's disease in a patient with IgA nephropathy.

Authors:  Yoshitaka Ueno; Shinji Tanaka; Toshiko Onitake; Rie Hanaoka; Kyoko Yoshioka; Masanori Ito; Kazuaki Chayama
Journal:  Clin J Gastroenterol       Date:  2009-10-03

2.  Spondyloarthritis-Associated IgA Nephropathy.

Authors:  Nicolas Champtiaux; Frédéric Lioté; Khalil El Karoui; Cécile Vigneau; Corinne Miceli; Emilie Cornec-Le Gall; Philippe Rémy; Gabriel Choukroun; Fadi Fakhouri; Cyril Garrouste; Laurent Veillon; Evangeline Pillebout; Thierry Lobbedez; Vincent Vuiblet; Alain Wynckel; Thomas Guincestre; Eric Toussirot; Eric Thervet; Marion Rabant; Alexandre Karras
Journal:  Kidney Int Rep       Date:  2020-03-16

3.  Paraneoplastic immunoglobulin A nephropathy and associated focal segmental glomerulosclerosis in asymptomatic low volume B-cell lymphoma - a case report.

Authors:  Monica Suet Ying Ng; Leo Francis; Elango Pillai; Andrew John Mallett
Journal:  BMC Nephrol       Date:  2018-09-10       Impact factor: 2.388

4.  IgA nephropathy in a patient receiving infliximab for generalized pustular psoriasis.

Authors:  Yuka Segawa; Ryo Ishida; Fuminao Kanehisa; Kunihiro Nakai; Mari Morimoto; Masafumi Seno; Mayuka Nakayama; Tetsuro Kusaba; Norito Katoh; Keiichi Tamagaki
Journal:  BMC Nephrol       Date:  2020-08-26       Impact factor: 2.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.